Are You Suffering From Hot Flashes? Hot flashes occur in up to 80% of men treated with ADT with 30-40% having moderate to severe hot flashes. Hot flashes are one of the most common and debilitating side effect of androgen deprivation therapy and ... Read more »
News
Urology of Virginia Was Just Named #11 Of The World’s Best Urology Bloggers
The Best Urology Blogs from thousands of Urology blogs on the web using search and social metrics. Subscribe to these websites because they are actively working to educate, inspire, and empower their readers with frequent updates and high-quality ... Read more »
Urology of Virginia’s own Dr . Ramon Virasoro : Meeting The Need For Safe Surgical Care
... Read more »
NAFC Names Chesapeake Regional a Center of Excellence with our very own Dr. Jennifer Miles Thomas
Contact: Tricia Hardy Media Relations Specialist Office: 757-312-6873 Cell: 757-408-2681 tricia.hardy@chesapeakeregional.com FOR IMMEDIATE RELEASE Dec. 4, 2018 NAFC NAMES CHESAPEAKE REGIONAL A CENTER OF EXCELLENCE Premier Pelvic ... Read more »
Aggressive prostate and lung cancers are driven by common mechanisms, researchers find
UCLA researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung. These shared molecular mechanisms could lead to the development of drugs to treat not just prostate and lung cancers, but ... Read more »
September is Prostate Cancer Awareness Month!
September is Prostate Cancer Awareness Month, and with prostate cancer holding a spot as one of the most common types of cancer among men, it is important to know the signs, symptoms and available treatments for this disease. Sentara Halifax Regional ... Read more »
Urology of Virginia Welcomes Dr. Sobol
Virginia Beach, VA – (08/27/2018): Urology of Virginia is proud to announce that beginning August 27, 2018 Dr. Sobol will begin seeing patients at its Harbor View location in Suffolk, VA. (7185 Harbour Towne Parkway, Suffolk, Va. 23434, ... Read more »
Our clinical trials…. Dr. Robert Given, M.D. F.A.C.S.
BREAKING NEWS: FDA Approves Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer ... Read more »
Potential Risks of Low-T Clinics: Why You Should Do Some Research Before Diving In
If you’ve read a newspaper, turned on a TV, or listened to the radio any time during the last five years, you’ve probably heard of low-T. The condition known as hypogonadism, or low-T, has been making headlines across America for the last few years. ... Read more »